» Authors » Andi Dian Permana

Andi Dian Permana

Explore the profile of Andi Dian Permana including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 683
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Burhanuddin H, Enggi C, Tangdilintin F, Saputra R, Putra P, Sartini S, et al.
Daru . 2024 Dec; 33(1):5. PMID: 39663291
Background: Amphotericin B (AMB) is a drug used to treat vulvovaginal candidiasis (VVC), which is a fungal infection affecting the vagina and vulva. Nevertheless, the substance's limited capacity to dissolve...
12.
Permana A, Maharani S, Aziz A, Ramadhany I, Himawan A, Habibie , et al.
Colloids Surf B Biointerfaces . 2024 Dec; 247():114416. PMID: 39637697
Deferasirox (DFX) is widely used to manage β-thalassemia major (β-TM), but its oral administration is limited by low bioavailability and side effects. To address these challenges, we developed iron-responsive nanoparticles...
13.
Samma A, Ko C, Sahra M, Fitrayani N, Thios F, Permana A
Ann Pharm Fr . 2024 Nov; PMID: 39613187
An antiviral prodrug that has received regulatory approval and primarily employed in the treatment of hepatitis C is sofosbuvir (SOF). It is therefore imperative to develop advanced delivery methods for...
14.
Permana A, Mahfud M, Munir M, Aries A, Rezka Putra A, Fikri A, et al.
ACS Appl Mater Interfaces . 2024 Nov; 16(49):68388-68406. PMID: 39591987
Alzheimer's disease (AD) often leads to dementia, causing cognitive decline and increased care needs. Rivastigmine (RV) is a key AD treatment, but its brain delivery is limited by the blood-brain...
15.
Sapiun Z, Imran A, S Mohamad S, Nur Aisyah A, Stephanie S, Himawan A, et al.
Int J Pharm . 2024 Sep; 666:124766. PMID: 39332463
Existing conventional antithrombosis drugs have caused many side effects, opening up opportunities for the development of new thrombotic drugs. There is potential to use the hispidulin-rich fraction of sesewanua (HRFS)...
16.
Maharani S, Hidayat M, Ramadhany I, Khairani N, Rahman N, Permana A
Mikrochim Acta . 2024 Sep; 191(10):587. PMID: 39251452
Deferiprone (DFP) is one of the iron-chelating agents used in iron overload therapy for patients with ß-thalassemia major (ß-TM). However, the use of DFP is limited as it experiences a...
17.
Tangdilintin F, Achmad A, Stephanie , Sulistiawati S, Enggi C, Wahyudin E, et al.
Langmuir . 2024 Aug; 40(35):18451-18465. PMID: 39169662
Skin can be damaged by intense and prolonged exposure to ultraviolet (UV) radiation. Photoaging and acute damage from sun exposure result in collagen degradation and enzymatic activity decline in the...
18.
Putri R, Enggi C, Sulistiawati S, Burhanuddin H, Iskandar I, Saputra R, et al.
J Biomater Sci Polym Ed . 2024 Jul; 35(15):2315-2342. PMID: 39083398
Itraconazole (ITZ) is one of the broad-spectrum antifungal agents for treating fungal keratitis. In clinical use, ITZ has problems related to its poor solubility in water, which results in low...
19.
Ilyas N, Putri A, Pratama F, Abdullah D, Azzahra K, Permana A
Eur J Pharm Biopharm . 2024 Jun; 201:114382. PMID: 38942175
Alzheimer's disease (ALZ) is a neurological disorder characterized by cognitive decline. Rivastigmine (RV), an acetylcholinesterase inhibitor, is commonly used to treat ALZ. Unfortunately, RV is availablein capsule form, which is...
20.
Achmad A, Tangdilintin F, Stephanie , Enggi C, Sulistiawati , Rifai Y, et al.
Eur J Pharm Biopharm . 2024 Jun; 202:114362. PMID: 38871091
Skin aging occurs naturally as essential skin components gradually decline, leading to issues such as fine lines, wrinkles, and pigmentation. Fucoidan, a natural bioactive compound, holds potential for addressing these...